THOMPSON SIEGEL & WALMSLEY LLC - FURIEX PHARMACEUTICALS INC ownership

FURIEX PHARMACEUTICALS INC's ticker is FURX and the CUSIP is 36106P101. A total of 92 filers reported holding FURIEX PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 5,860.00 and the average weighting 0.3%.

Quarter-by-quarter ownership
THOMPSON SIEGEL & WALMSLEY LLC ownership history of FURIEX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2014$31,709,000
+25.7%
364,463
-39.3%
0.71%
+21.0%
Q4 2013$25,232,000
+4.0%
600,615
+8.9%
0.59%
+12.0%
Q3 2013$24,265,000
+90.1%
551,606
+47.3%
0.53%
+90.9%
Q2 2013$12,761,000374,5770.28%
Other shareholders

There were no reported owners of FURIEX PHARMACEUTICALS INC in Q2 2013.

NameSharesValueWeighting ↓
View complete list of FURIEX PHARMACEUTICALS INC shareholders